Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2190915 PK/PD and Safety in Pediatric Asthma
NCT01286844Phase 2Withdrawn
- Sponsor
- GSK
- Start
- Nov 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of fiboflapon in asthma (2 cohorts), sponsored by GSK. Primary endpoint: Derived plasma pharmacokinetic parameters at 24 hours. Planned start Nov 2010; status: withdrawn.
02
Drugs
fiboflapon
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01286844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01286844.